Government Briefs

Differing Views On AIDS Funding Scientists who don't receive federal funds to do AIDS research think that the government's AIDS program has drained away research dollars from other fields. But scientists who receive such funds think those other disciplines have not been affected. These findings are part of a survey by the congressional Office of Technology Assessment, sent to 400 members of the Institute of Medicine. The survey was actually conducted to measure the impact of AIDS research on ot


Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Differing Views On AIDS Funding Scientists who don't receive federal funds to do AIDS research think that the government's AIDS program has drained away research dollars from other fields. But scientists who receive such funds think those other disciplines have not been affected. These findings are part of a survey by the congressional Office of Technology Assessment, sent to 400 members of the Institute of Medicine. The survey was actually conducted to measure the impact of AIDS research on other fields, and the 142 respondents pointed to major contributions in immunology, virology, molecular biology, and microbiology. But when it came to judging federal spending priorities, OTA confirmed the adage that where you sit is the best indicator of where you stand on a particular issue. Some 73 percent of the scientists who don't get federal funds and don't do AIDS-related research believed that AIDS funding was squeezing other fields, while ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide